Laboratory Diagnostic and Monitoring at Early Stages of SARS-CoV-2 Infection: Case Report and Literature Review
DOI:
https://doi.org/10.24293/ijcpml.v29i1.1952Keywords:
COVID-19, early stages of SARS-CoV-2, laboratory diagnosisAbstract
COVID-19 is a new respiratory disease caused by severe acute respiratory syndrome Coronavirus type 2 (SARS-CoV-2) and became a pandemic in early 2020. Since the clinical presentation of this viral infection can mimic other types of viral infection (e.g., dengue, influenza, and another respiratory disease), the laboratory approach becomes essential, particularly at the early stages of infection. This case-literature review approach described an outpatient case of a 39-year-old male patient with mild-to-moderate COVID-19 who recovered after 49 days of self-quarantine. Lymphopenia and mild thrombocytopenia can be used as early screening for COVID-19 at the early stages of infection and mainly occur in outpatient settings. Meanwhile, Neutrophil-to-Lymphocyte Count Ratio (NLCR), C-Reactive Protein (CRP), and Liver Function Test (LFT) can be used for severity prediction and/or follow-up the outcome of the infected patient. Therefore, the integrated clinical-laboratory finding at the early stages of infection is vital to provide better and effective patient management.
Downloads
References
Chen N, Zhou M, Dong X, Qu J, Han Y, et al. Epidemiological and clinical characteristics of 99 cases
of 2019 novel Coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 2020; 395: 507-13.
Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis, and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis, 2020; 1866: 165878.
Guan W, Ni Z, Hu Y, Liang W, Ou C, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Eng J Med, 2020; 382: 1708-20.
Zhao Z, Xie J, Yin M, Yang Y, He H, et al. Clinical and laboratory profiles of 75 hospitalized patients with
novel Coronavirus disease 2019 in Hefei, China. Infectious Diseases (except HIV/AIDS); 2020. Available
f r o m : h t t p :// m e d r x i v . o r g /l o o k u p / d o i/10.1101/2020.03.01.20029785 (accessed May 3,
.
Cao M, Zhang D, Wang Y, Lu Y, Zhu X, et al. Clinical features of patients infected with the 2019 novel
Coronavirus (COVID-19) in Shanghai, China. Respiratory Medicine, 2020. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.03.04.2003039 (accessed May 3, 2020).
Burhan E, Isbaniah F, Susanto AD, Aditama TY, Soedarsono, et al. Pneumonia COVID-19: Diagnosis &
penatalaksanaan di Indonesia. 2020. Available from: https://klikpdpi.com/bukupdpi/wp-content/
uploads/2020/04/Buku-Pneumonia-COVID-19-PDPI-2020. pdf (accessed March 10, 2021).
Kementerian Kesehatan Republik Indonesia. Pedoman pencegahan dan pengendalian Coronavirus Disease (COVID-19). 2020. Available from: https://covid19.go.id/p/protokol/pedoman-pencegahan-dan
-pengendalian-coronavirus-disease-covid-19-revisi -ke-5 (accessed February 1, 2021).
Nilles KM, Caldwell SH, Flamm SL. Thrombocytopenia and Procedural Prophylaxis in the era of
thrombopoietin receptor agonists. Hepatol Commun. 2019; 3: 1423-34.
Liao D, Zhou F, Luo L, Xin M, Wang H, et al. Haematological characteristics and risk factors in the
classification and prognosis evaluation of COVID-19: A retrospective cohort study. Lancet Haematol, 2020; 7: e671-8.
Pereyra D, Heber S, Jilma B, Zoufaly A, Assinger A. Routine hematological parameters in COVID-19
prognosis. Lancet Haematol, 2020; 7: e709.
Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in
patients with severe Coronavirus Disease 2019 (COVID?19): A meta?analysis. J Med Virol, 2020; 92: 1733-4.
Liu J, Liu Y, Xiang P, Pu L, Xiong H, et al. Neutrophil-to -Lymphocyte ratio predicts severe illness patients with 2019 novel Coronavirus in the early stage. Infectious Diseases (except HIV/AIDS); 2020. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.02.10.20021584 (accessed May 3, 2020).
Ai J, Chen J, Wang Y, Liu X, Fan W, et al. The cross-sectional study of hospitalized Coronavirus
disease 2019 patients in Xiangyang, Hubei province. Infectious Diseases (except HIV/AIDS); 2020. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.02.19.20025023 (accessed May 3, 2020).
Bertolini A, Peppel IP, Bodewes FAJA, Moshage H, Fantin A, et al. Abnormal liver function tests in patients with COVID-19: Relevance and potential pathogenesis. Hepatology 2020; 72: 1864-72.
Chen G, Wu D, Guo W, Cao Y, Huang D, et al. Clinical and immunologic features in severe and moderate forms of Coronavirus disease 2019. Infectious Diseases (except HIV/AIDS), 2020. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.02.16.20023903 (accessed May 3, 2020).
Shi Q, Zhao K, Yu J, Jiang F, Feng J, et al. Clinical characteristics of 101 COVID-19 nonsurvivors in
Wuhan, China: A retrospective study. Infectious Diseases (except HIV/AIDS); 2020. Available from:
http://medrxiv.org/lookup/doi/10.1101/2020.03.04.2 0031039 (accessed May 3, 2020).
Wang Y, Zhou Y, Yang Z, Xia D, Geng S. Clinical characteristics of patients with severe pneumonia
caused by the 2019 novel Coronavirus in Wuhan, China. Infectious Diseases (except HIV/AIDS);
Available from: http://medrxiv.org/lookup/doi/10.1101/2020.03.02.20029306 (accessed May 3,
.
Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, et al. Clinical characteristics of 140 patients infected with
SARS?CoV?2 in Wuhan, China. Allergy 2020. Available f r o m : h t t p s :// o n l i n e l i b r a r y . w i l e y . c o m /doi/abs/10.1111/all.14238 (accessed May 3, 2020).
Yan S, Song X, Lin F, Zhu H, Wang X, et al. Clinical characteristics of Coronavirus disease 2019 in Hainan, China. Infectious Diseases (except HIV/AIDS); 2020. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.03.19.20038539 (accessed May 3, 2020).
Liu Y, Sun W, Li J, Chen L, Wang Y, et al. Clinical features and progression of acute respiratory distress
syndrome in Coronavirus disease 2019. Intensive Care and Critical Care Medicine, 2020. Available from:
http://medrxiv.org/lookup/doi/10.1101/2020.02.17.20024166 (accessed May 3, 2020).
Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel
Coronavirus in Wuhan, China. The Lancet 2020; 395: 497-506.
Xu X-W, Wu X-X, Jiang X-G, Xu K, Ying L, et al. Clinical findings in a group of patients infected with the 2019 novel Coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ, 2020; m606.
Li J, Li S, Cai Y, Liu Q, Li X, et al. Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 novel Coronavirus infections outside Wuhan, China. Epidemiology, 2020. Available from:
http://medrxiv.org/lookup/doi/10.1101/2020.02.11.20022053 (accessed May 3, 2020).
Selanno Y, Widaningsih Y, Esa T, Arif M. Analysis of neutrophil-lymphocyte ratio and absolute
lymphocyte count as predictors of severity of COVID-19 patients. Indonesian J Clin Pathol Med Lab,
; 27(2): 184.
Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA, 2020; 323: 2249.
Abbasi J. The flawed science of antibody testing for SARS-CoV-2 immunity. JAMA, 2021; 326: 1781.
Durant TJS, Peaper DR, Ferguson D, Schulz WL. Impact of COVID-19 pandemic on laboratory utilization. J Appl Lab Med, 2020; 5: 1194-205.
Gillies MB, Burgner DP, Ivancic L, Nassar N, Miller J, et al. Changes in antibiotic prescribing following
COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship. Br J Clin Pharmacol, 2021;
bcp.15000.
Langford BJ, So M, Raybardhan S, Leung V, Westwood D, et al. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin Microbiol Infect, 2020; 26: 1622-9.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
